RBMY1A1 and hepatocellular carcinoma: Data mining of IHC analyses of HCC specimens also confirmed the oncogenic properties of RBMY in HCC, however, overexpression of RBMY in an HCC cell line HuH-7 and a hepatoblastoma cell line HepG2 showed an inhibitory effect on cell proliferation.